Market Research Logo

France Diabetes Care Devices Market Outlook to 2022 - Glucose Monitoring and Insulin Delivery

France Diabetes Care Devices Market Outlook to 2022 - Glucose Monitoring and Insulin Delivery

Summary

GlobalData’s new report, France Diabetes Care Devices Market Outlook to 2022, provides key market data on the France Diabetes Care Devices market. The report provides value, in millions of US dollars and volume (in units) within market categories - Glucose Monitoring and Insulin Delivery.

The report also provides company shares and distribution shares data for the market category, and global corporate-level profiles of the key market participants. Based on the availability of data for the particular category and country, information related to pipeline products, news and deals is available in the report.

Extensive interviews are conducted with key opinion leaders (KOLs), physicians and industry experts to validate the market size, company share and distribution share data and analysis.

Scope

  • Market size for Diabetes Care Devices market categories - Glucose Monitoring and Insulin Delivery.
  • Annualized market revenues (USD million) and volume (units) data for each of the market categories. Data is provided from 2008 to 2015 and forecast to 2022.
  • 2015 company shares and distribution shares data for Diabetes Care Devices market.
  • Global corporate-level profiles of key companies operating within the France Diabetes Care Devices market.
  • Key players covered include LifeScan Inc, Medtronic plc, Bayer HealthCare AG, F. Hoffmann-La Roche Ltd and others.
Reasons to buy
  • Develop business strategies by identifying the key market segments poised for strong growth in the future.
  • Develop market-entry and market expansion strategies.
  • Design competition strategies by identifying who-stands-where in the market.
  • Develop investment strategies by identifying the key market segments expected to register strong growth in the near future.
  • What are the key distribution channels and what’s the most preferred mode of product distribution - Identify, understand and capitalize.


1 Table of Contents
1.1 List of Tables
1.2 List of Figures
2 Introduction
2.1 What Is This Report About?
2.2 Diabetes Care Devices Market Segmentation
2.3 Definitions of Markets Covered in the Report
3 Diabetes Care Devices Market, France
3.1 Diabetes Care Devices Market, France, Revenue ($m), 2008-2022
3.2 Diabetes Care Devices Market, France, Revenue Mix ($m), 2015
3.3 Diabetes Care Devices Market, France, Category Contribution by Revenue ($m), 2015
3.4 Diabetes Care Devices Market, France, Revenue ($m), 2008-2015
3.5 Diabetes Care Devices Market, France, Revenue ($m), 2015-2022
3.6 Diabetes Care Devices Market, France, Volume (Units), 2008-2022
3.7 Diabetes Care Devices Market, France, Volume (Units), 2008-2015
3.8 Diabetes Care Devices Market, France, Volume (Units), 2015-2022
3.9 Diabetes Care Devices Market, France, Company Share by Revenue ($m), 2015
4 Glucose Monitoring Market, France
4.1 Glucose Monitoring Market, France, Revenue Mix ($m), 2015
4.2 Glucose Monitoring Market, France, Segment Contribution (%), 2015
4.3 Glucose Monitoring Market, France, Revenue ($m), 2008-2015
4.4 Glucose Monitoring Market, France, Revenue ($m), 2015-2022
4.4.1 Blood Glucose Meters Market, France, Revenue ($m), by Segment, 2008-2015
4.4.2 Blood Glucose Meters Market, France, Revenue ($m), by Segment, 2015-2022
4.5 Glucose Monitoring Market, France, Volume (Units), 2008-2015
4.6 Glucose Monitoring Market, France, Volume (Units), 2015-2022
4.6.1 Blood Glucose Meters Market, France, Volume (Units), by Segment, 2008-2015
4.6.2 Blood Glucose Meters Market, France, Volume (Units), by Segment, 2015-2022
4.7 Glucose Monitoring Market, France, Distribution Share by Revenue ($m), 2014-2015
4.8 Glucose Monitoring Market, France, Company Share by Revenue ($m), 2015
5 Insulin Delivery Market, France
5.1 Insulin Delivery Market, France, Revenue Mix ($m), 2015
5.2 Insulin Delivery Market, France, Segment Contribution (%), 2015
5.3 Insulin Delivery Market, France, Revenue ($m), 2008-2015
5.4 Insulin Delivery Market, France, Revenue ($m), 2015-2022
5.4.1 Insulin Pens Market, France, Revenue ($m), by Segment, 2008-2015
5.4.2 Insulin Pumps Market, France, Revenue ($m), by Segment, 2008-2015
5.4.3 Insulin Pens Market, France, Revenue ($m), by Segment, 2015-2022
5.4.4 Insulin Pumps Market, France, Revenue ($m), by Segment, 2015-2022
5.5 Insulin Delivery Market, France, Volume (Units), 2008-2015
5.6 Insulin Delivery Market, France, Volume (Units), 2015-2022
5.6.1 Insulin Pens Market, France, Volume (Units), by Segment, 2008-2015
5.6.2 Insulin Pumps Market, France, Volume (Units), by Segment, 2008-2015
5.6.3 Insulin Pens Market, France, Volume (Units), by Segment, 2015-2022
5.6.4 Insulin Pumps Market, France, Volume (Units), by Segment, 2015-2022
5.7 Insulin Delivery Market, France, Distribution Share by Revenue ($m), 2014-2015
5.8 Insulin Delivery Market, France, Company Share by Revenue ($m), 2015
6 Overview of Key Companies in France, Diabetes Care Devices Market
6.1 Sanofi
6.1.1 Company Overview
6.2 F. Hoffmann-La Roche Ltd
6.2.1 Company Overview
6.3 LifeScan Inc
6.3.1 Company Overview
6.4 Bayer HealthCare AG
6.4.1 Company Overview
6.5 Eli Lilly and Company
6.5.1 Company Overview
6.6 Abbott Laboratories
6.6.1 Company Overview
6.7 Medtronic plc
6.7.1 Company Overview
6.8 Novo Nordisk A/S
6.8.1 Company Overview
6.9 Ypsomed Holding AG
6.9.1 Company Overview
6.10 Becton Dickinson and Co
6.10.1 Company Overview
6.11 Arkray Inc
6.11.1 Company Overview
7 Diabetes Care Devices Market Pipeline Products
8 Financial Deals Landscape
8.1 Equity Offerings
8.1.1 Defymed Receives Investment from JDRF
8.2 Partnerships
8.2.1 Defymed Enters into Agreement with Semma Therapeutics
8.2.2 Tandem Diabetes Care Enters into Licensing Agreement with TypeZero Technologies
8.2.3 Senseonics Amends its Distribution Agreement with F. Hoffmann-La Roche
8.2.4 Medtronic and Qualcomm Life Enter into Co-Development Agreement
8.2.5 Metabolon Enters into Licensing Agreement with Synlab
8.2.6 Cellnovo Enters into Agreement with Roche Diagnostics
9 Recent Developments
9.1 Corporate Communications
9.1.1 Sep 30, 2016: Sanofi Appoints Alan Main to Executive Committee and Executive Vice President, Consumer Healthcare
9.1.2 Sep 07, 2016: Sanofi Appoints New Research Head for Immunology and Inflammation
9.1.3 Sep 06, 2016: Sanofi Board Of Directors Provides Update
9.1.4 Aug 15, 2016: MMJ PhytoTech to Commence Phase 2 Clinical Trial on Pediatric Epilepsy
9.1.5 May 23, 2016: Sanofi Announces Changes to Executive Committee Aligned to its Strategic Roadmap 2020
9.1.6 May 05, 2016: Encore Vision Announces Successful Phase I-II Study of Topical EV06 for the Treatment of Presbyopia
9.1.7 Mar 29, 2016: Sanofi Appoints Dr. Yong-Jun Liu as Head of Research
9.1.8 Mar 10, 2016: Sanofi Appoints Dr. Ameet Nathwani to Executive Committee and Executive Vice President, Group Chief Medical Officer
9.2 Financial Announcements
9.2.1 Oct 28, 2016: Sanofi Announces Strong Q3 2016 Results
9.2.2 Aug 16, 2016: vTv Therapeutics Completes Enrollment of Phase 2 Trial Evaluating TTP273 for the Treatment of Type 2 Diabetes
9.2.3 Aug 16, 2016: OncoGenex Announced Results from the Phase 3 AFFINITY Trial of Custirsen in Men with Metastatic Castrate-Resistant Prostate Cancer
9.2.4 Jul 29, 2016: Sanofi Announces Q2 2016 Results
9.2.5 Jul 29, 2016: Royalty report for Q2 2016 and update on lixisenatide (Lyxumia/Adlyxin) and iGlarLixi
9.2.6 Apr 29, 2016: Solid Performance in the First Quarter of 2016 with Business EPS up 5.3% at Constant Exchange Rates
9.2.7 Mar 14, 2016: Chiasma Initiates Phase 3 Trial to Support European Registration of Octreotide Capsules for Patients with Acromegaly
9.2.8 Feb 09, 2016: Sanofi Delivered 2015 Business EPS Up 8.5% On A Reported Basis And Stable At Constant Exchange Rates Consistent With Guidance
9.3 Government and Public Interest
9.3.1 Jun 13, 2016: Sanofi Files Definitive Consent Solicitation To Remove And Replace Medivation’s Board
9.3.2 Jun 01, 2016: Sanofi Requests Record Date for Consent Solicitation to Remove and Replace Medivation’s Board of Directors
9.4 Other Significant Developments
9.4.1 May 25, 2016: Sanofi Files Consent Solicitation To Remove and Replace Medivation’s Board
9.4.2 Apr 19, 2016: Sanofi Invests €300 Million To Expand Biologics Site in Belgium
9.4.3 Apr 19, 2016: Sanofi Invests €300 Million in its Biologics Site in Belgium to Develop its Monoclonal Antibodies Portfolio
9.5 Strategy And Business Planning
9.5.1 Jul 05, 2016: Sanofi Enters Into Confidentiality Agreement With Medivation And Will Be Provided Due Diligence Access And Confidential Information
9.5.2 Apr 19, 2016: Sanofi Invests €300 Million To Expand Biologics Site in Belgium
10 Appendix
10.1 Research Methodology
10.1.1 Coverage
10.1.2 Secondary Research
10.1.3 Primary Research
10.1.4 Company Share Analysis
10.1.5 Distribution Share Analysis
10.1.6 Benchmarking
10.2 GlobalData Consulting
10.3 Contact Us
10.4 Disclaimer
1.1 List of Tables
Table 1: Diabetes Care Devices Market, France, Revenue ($m), USD Constant, 2008-2022
Table 2: Diabetes Care Devices Market, France, Category Contribution by Revenue ($m), 2015
Table 3: Diabetes Care Devices Market, France, Revenue ($m), USD Constant, Historic, 2008-2015
Table 4: Diabetes Care Devices Market, France, Revenue ($m), USD Constant, Forecast, 2015-2022
Table 5: Diabetes Care Devices Market, France, Volume (Units), 2008-2022
Table 6: Diabetes Care Devices Market, France, Volume (Units), Historic, 2008-2015
Table 7: Diabetes Care Devices Market, France, Volume (Units), Forecast, 2015-2022
Table 8: Diabetes Care Devices Market, France, Company Share by Revenue ($m), USD Constant, 2015
Table 9: Glucose Monitoring Market, France, Segment Contribution (%), 2015
Table 10: Glucose Monitoring Market, France, Revenue ($m), USD Constant, Historic, 2008-2015
Table 11: Glucose Monitoring Market, France, Revenue ($m), USD Constant, Forecast, 2015-2022
Table 12: Blood Glucose Meters Market, France, Revenue ($m), USD Constant, Historic, 2008-2015
Table 13: Blood Glucose Meters Market, France, Revenue ($m), USD Constant, Forecast, 2015-2022
Table 14: Glucose Monitoring Market, France, Volume (Units), Historic, 2008-2015
Table 15: Glucose Monitoring Market, France, Volume (Units), Forecast, 2015-2022
Table 16: Blood Glucose Meters Market, France, Volume (Units), Historic, 2008-2015
Table 17: Blood Glucose Meters Market, France, Volume (Units), Forecast, 2015-2022
Table 18: Glucose Monitoring Market, France, Distribution Share by Revenue ($m), USD Constant, 2014-2015
Table 19: Glucose Monitoring Market, France, Company Share by Revenue ($m), USD Constant, 2015
Table 20: Insulin Delivery Market, France, Segment Contribution (%), 2015
Table 21: Insulin Delivery Market, France, Revenue ($m), USD Constant, Historic, 2008-2015
Table 22: Insulin Delivery Market, France, Revenue ($m), USD Constant, Forecast, 2015-2022
Table 23: Insulin Pens Market, France, Revenue ($m), USD Constant, Historic, 2008-2015
Table 24: Insulin Pumps Market, France, Revenue ($m), USD Constant, Historic, 2008-2015
Table 25: Insulin Pens Market, France, Revenue ($m), USD Constant, Forecast, 2015-2022
Table 26: Insulin Pumps Market, France, Revenue ($m), USD Constant, Forecast, 2015-2022
Table 27: Insulin Delivery Market, France, Volume (Units), Historic, 2008-2015
Table 28: Insulin Delivery Market, France, Volume (Units), Forecast, 2015-2022
Table 29: Insulin Pens Market, France, Volume (Units), Historic, 2008-2015
Table 30: Insulin Pumps Market, France, Volume (Units), Historic, 2008-2015
Table 31: Insulin Pens Market, France, Volume (Units), Forecast, 2015-2022
Table 32: Insulin Pumps Market, France, Volume (Units), Forecast, 2015-2022
Table 33: Insulin Delivery Market, France, Distribution Share by Revenue ($m), USD Constant, 2014-2015
Table 34: Insulin Delivery Market, France, Company Share by Revenue ($m), USD Constant, 2015
Table 35: Diabetes Care Devices Market Pipeline Products
Table 36: Defymed Receives Investment from JDRF
Table 37: Defymed Enters into Agreement with Semma Therapeutics
Table 38: Tandem Diabetes Care Enters into Licensing Agreement with TypeZero Technologies
Table 39: Senseonics Amends its Distribution Agreement with F. Hoffmann-La Roche
Table 40: Medtronic and Qualcomm Life Enter into Co-Development Agreement
Table 41: Metabolon Enters into Licensing Agreement with Synlab
Table 42: Cellnovo Enters into Agreement with Roche Diagnostics
1.2 List of Figures
Figure 1: Diabetes Care Devices Market, France, Revenue ($m), USD Constant, 2008-2022
Figure 2: Diabetes Care Devices Market, France, Revenue Mix ($m), 2015
Figure 3: Diabetes Care Devices Market, France, Category Contribution (%), 2015
Figure 4: Diabetes Care Devices Market, France, Revenue ($m), USD Constant, Historic, 2008-2015
Figure 5: Diabetes Care Devices Market, France, Revenue ($m), USD Constant, Forecast, 2015-2022
Figure 6: Diabetes Care Devices Market, France, Volume (Units), 2008-2022
Figure 7: Diabetes Care Devices Market, France, Volume (Units), Historic, 2008-2015
Figure 8: Diabetes Care Devices Market, France, Volume (Units), Forecast, 2015-2022
Figure 9: Diabetes Care Devices Market, France, Company Share (%) 2015
Figure 10: Glucose Monitoring Market, France, Revenue Mix ($m), 2015
Figure 11: Glucose Monitoring Market, France, Segment Contribution (%), 2015
Figure 12: Glucose Monitoring Market, France, Revenue ($m), USD Constant, Historic, 2008-2015
Figure 13: Glucose Monitoring Market, France, Revenue ($m), USD Constant, Forecast, 2015-2022
Figure 14: Blood Glucose Meters Market, France, Revenue ($m), USD Constant, Historic, 2008-2015
Figure 15: Blood Glucose Meters Market, France, Revenue ($m), USD Constant, Forecast, 2015-2022
Figure 16: Glucose Monitoring Market, France, Volume (Units), Historic, 2008-2015
Figure 17: Glucose Monitoring Market, France, Volume (Units), Forecast, 2015-2022
Figure 18: Blood Glucose Meters Market, France, Volume (Units), Historic, 2008-2015
Figure 19: Blood Glucose Meters Market, France, Volume (Units), Forecast, 2015-2022
Figure 20: Glucose Monitoring Market, France, Company Share (%) 2015
Figure 21: Insulin Delivery Market, France, Revenue Mix ($m), 2015
Figure 22: Insulin Delivery Market, France, Segment Contribution (%), 2015
Figure 23: Insulin Delivery Market, France, Revenue ($m), USD Constant, Historic, 2008-2015
Figure 24: Insulin Delivery Market, France, Revenue ($m), USD Constant, Forecast, 2015-2022
Figure 25: Insulin Pens Market, France, Revenue ($m), USD Constant, Historic, 2008-2015
Figure 26: Insulin Pumps Market, France, Revenue ($m), USD Constant, Historic, 2008-2015
Figure 27: Insulin Pens Market, France, Revenue ($m), USD Constant, Forecast, 2015-2022
Figure 28: Insulin Pumps Market, France, Revenue ($m), USD Constant, Forecast, 2015-2022
Figure 29: Insulin Delivery Market, France, Volume (Units), Historic, 2008-2015
Figure 30: Insulin Delivery Market, France, Volume (Units), Forecast, 2015-2022
Figure 31: Insulin Pens Market, France, Volume (Units), Historic, 2008-2015
Figure 32: Insulin Pumps Market, France, Volume (Units), Historic, 2008-2015
Figure 33: Insulin Pens Market, France, Volume (Units), Forecast, 2015-2022
Figure 34: Insulin Pumps Market, France, Volume (Units), Forecast, 2015-2022
Figure 35: Insulin Delivery Market, France, Company Share (%) 2015

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report